Question 1

What is the catalog number for A 740?

Accepted Answer

The catalog number for A 740 is T29503.

Question 2

What sizes are available for A 740?

Accepted Answer

A 740 is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does A 740 come in?

Accepted Answer

A 740 is available in 3 different pack sizes.

Question 4

Is A 740 in stock?

Accepted Answer

A 740 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures A 740?

Accepted Answer

A 740 is manufactured by Molfinity.

Question 6

What is the estimated delivery time for A 740?

Accepted Answer

Estimated delivery time for A 740 is approximately 10 business day(s), depending on your location.

Question 7

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 8

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 9

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

A 740

Product Specifications

CAS Number

Target

Related Pathways

Bioactivity

Smiles

Molecular Formula

Molecular Weight

Shipping Conditions

Storage Temperature

Available Sizes

Frequently Asked Questions

Explore Other Products

GW806742X

IGF2BP3 Antibody, Biotin conjugated

IGF2BP3 Antibody, Biotin conjugated

Mouse Fgf12 Pre-designed siRNA Set B

N3, N3, N6, N6-Tetrakis[4- (dibutylamino) phenyl]-1,4-cyclohexadiene-3,6-diaminium hexafluoroantimonate (1:2)

LPL Peptide - middle region